home / stock / bysi / bysi news

BYSI News and Press, BeyondSpring Inc. From 01/10/20

Stock Information
Company Name: BeyondSpring Inc.
Stock Symbol: BYSI
Market: NASDAQ
Website: beyondspringpharma.com
Menu
BYSI BYSI Quote BYSI Short BYSI News BYSI Articles BYSI Message Board
Get BYSI Alerts

News, Short Squeeze, Breakout and More Instantly...
BYSI - Kadmon, BeyondSpring gain a bull as Nomura picks up coverage

BeyondSpring (NASDAQ: BYSI )  rises 2.7%  and Kadmon Holdings (NYSE: KDMN ) also  gains 2.7%  after Nomura Instinet initiates coverage of the two companies at Buy. More news on: BeyondSpring Inc., Kadmon Holdings, Inc., Healthcare stocks news, Stocks on the move, Re...
BYSI - Morgan Stanley sees 15% upside in McKesson in premarket analyst action

Aerie Pharmaceuticals (NASDAQ: AERI ) initiated with Neutral rating and $27 (6% upside) price target at Bank of America. More news on: Aurinia Pharmaceuticals Inc., BeyondSpring Inc., Cerecor Inc., Healthcare stocks news, Stocks on the move, , Read more ...

BYSI - BeyondSpring Strengthens Executive Rank for Pipeline Expansion and Commercialization Readiness in China

Dr. James Tonra Promoted to Chief Scientific Officer Roland Liu Named Chief Commercial Officer for China Subsidiary NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceut...

BYSI - BeyondSpring Publishes Report on Benefits and Mechanism of Plinabulin in Reducing Neutropenia with Multiple Chemotherapies

NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the peer reviewed journal Cancer Chemotherapy and Pharmacology published ...
BYSI - BeyondSpring Inc. (BYSI) Q3 2019 Earnings Call Transcript

Image source: The Motley Fool. BeyondSpring Inc.   (NASDAQ: BYSI) Q3 2019 Earnings Call Dec 18, 2019 , 8:00 a.m. ET Operator Continue reading

BYSI - BeyondSpring Inc. (BYSI) CEO Lan Huang on Q3 2019 Results - Earnings Call Transcript

BeyondSpring Inc. (BYSI) Q3 2019 Earnings Conference Call December 18, 2019 8:00 A.M. ET Company Participants David Schemelia - Senior Vice President, KCSA Strategic Communications Lan Huang - Chairman and Chief Executive Officer Ramon Mohanlal - Executive Vice President of Resea...

BYSI - BeyondSpring EPS misses by $0.07

BeyondSpring (NASDAQ: BYSI ): Q3 GAAP EPS of -$0.37 misses by $0.07 . More news on: BeyondSpring Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BYSI - BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update

Preparing to Submit NDA in China for Chemotherapy-Induced Neutropenia (“CIN”) in Q1 2020 Plinabulin’s Anti-Cancer and CIN Prevention Mechanism Published in Peer Reviewed Journals NEW YORK, Dec. 18, 2019 (GLOBE NEWSWIRE) --  BeyondSpring Inc. (the ...

BYSI - BeyondSpring to Host Third-Quarter 2019 Financial Results and Operational Update Conference Call on December 18, 2019

NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company will host its third-quar...

BYSI - BeyondSpring's Study 106 Phase 3 Superior Trial Design Combining Plinabulin with Pegfilgrastim Versus Pegfilgrastim Alone for Chemotherapy-Induced Neutropenia Presented at ASH 2019 Annual Meeting

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company’s abstract for its Phase 3 Study 106 clinical trial design ...
Previous 10 Next 10